Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor
[EN] QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER<br/>[FR] DÉRIVÉS DE QUINOLÉINE ET LEURS UTILISATIONS DANS LA GESTION DU CANCER
申请人:UNIV EMORY
公开号:WO2021050721A1
公开(公告)日:2021-03-18
Provided herein are compounds, pharmaceutical compositions including such compounds, and methods of using such compounds to treat diseases or disorders associated with MDM2 activity.
Discovery of <i>N</i>-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-<i>c</i>]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor
作者:Zhongzhi Wu、Lubing Gu、Sicheng Zhang、Tao Liu、Pradeep B. Lukka、Bernd Meibohm、John C. Bollinger、Muxiang Zhou、Wei Li